They're doing the hard work of building clinical data infrastructure across 90+ hospitals in Asia and the Middle East so global pharma can bring drugs to market faster.
Proud we got to lead their pre-seed from day one.
They're doing the hard work of building clinical data infrastructure across 90+ hospitals in Asia and the Middle East so global pharma can bring drugs to market faster.
Proud we got to lead their pre-seed from day one.
While SV focuses on foundation models and compute, we focus on unique data to solve real industry problems. The big opportunity isn't building LLMs—it's embedding AI into traditional businesses so they actually make money.
While SV focuses on foundation models and compute, we focus on unique data to solve real industry problems. The big opportunity isn't building LLMs—it's embedding AI into traditional businesses so they actually make money.
Markets reward customer proof, repeatable sales and positive unit economics.
Read our full breakdown on founder patterns investors misread
Markets reward customer proof, repeatable sales and positive unit economics.
Read our full breakdown on founder patterns investors misread
If you're at LEAP from August 31st to September 3rd, make sure to catch this discussion.
If you're at LEAP from August 31st to September 3rd, make sure to catch this discussion.